This article was written by Follow Bret Jensen has over 13 years as a market analyst, helping investors find big winners in the biotech sector. Bret specializes in high beta sectors with
Beijing — Chinese electric-vehicle maker Xpeng has announced plans to launch a cheaper brand, entering a highly competitive segment amid intense price competition in
Poseida Therapeutics (NASDAQ:PSTX) is expected to release results from the phase 1 study using P-BCMA-ALLO1 for the treatment of patients with relapsed or refractory